Delving into the Latest Updates on N0728 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Urogenital DiseasesOther Diseases

Active Indication

Lower Urinary Tract SymptomsProstatic Hyperplasia

Inactive Indication-

Originator Organization

Eurofarma Laboratórios SA

Active Organization

Eurofarma Laboratórios SA

Inactive Organization-

Drug Highest PhasePhase 3

First Approval Date-

Regulation-

Login to view timeline

The clinical trial to evaluate the fixed-dose combination (N0728), with the aim of providing the Brazilian market with an alternative, potentially effective, safe and convenient therapeutic approach for the treatment of Lower Urinary Tract Symptoms (LUTS) in men with Benign Prostatic Hyperplasia (BPH). The fixed-dose combination has synergistic action between drugs from different classes and offers significant potential advantages, such as better adherence to treatment. The trial will assess the non-inferiority in efficacy and safety of the proposed fixed-dose combination compared to alpha-adrenergic antagonists.

Start Date30 Nov 2026

Sponsor / Collaborator

Eurofarma Laboratórios SA

100 Clinical Results associated with N0728

Login to view more data

100 Translational Medicine associated with N0728

Login to view more data

100 Patents (Medical) associated with N0728

Login to view more data

100 Deals associated with N0728

Login to view more data